Covance doubles capacity with new R&D center in China
Covance opens a new facility in Shanghai, its biggest in Asia Pacific, to boost its research and development services offering.
Covance opens a new facility in Shanghai, its biggest in Asia Pacific, to boost its research and development services offering.
The pharmaceutical and biotech product development consultancy Boyds acquires Blue Duck Consulting to boost its clinical and medical affairs services offering.
Charles River has added to its microbial solutions offering with two new products that aim to reduce risk and increase the efficiency of drug testing.
Civica agrees a deal with Exela to secure the supply of sodium bicarbonate injections to distribute through its hospital network due to ‘ongoing shortages’.
The FDA has extended its agreement with CluePoints to augment the agency’s oversight of clinical trials using data-driven approaches, with additional testing ideas focusing on moderators of treatment effect and real-world evidence, says CCO.